Evidence map›Paper›PMID 24353182›Full record

ArticleDiabetes2014

Peroxynitrite disrupts endothelial caveolae leading to eNOS uncoupling and diminished flow-mediated dilation in coronary arterioles of diabetic patients.

James Cassuto, Huijuan Dou, Istvan Czikora, Andras Szabo, Vijay S Patel, Vinayak Kamath, Eric Belin de Chantemele, Attila Feher, Maritza J Romero, Zsolt Bagi

Open access · hybridAbstract read
In one paragraph

Article in Diabetes, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 115 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Endothelial Dysfunction in Obesity and Therapeutic Targets.Advances in experimental medicine and biology · 2024
    Review
  15. The damaging duo: Obesity and excess dietary salt contribute to hypertension and cardiovascular disease.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2023
    Review
  16. Article
  17. Article
  18. Review
  19. The mechanism and therapy of aortic aneurysms.Signal transduction and targeted therapy · 2023
    Review
  20. Review

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

James CassutoVascular Biology Center, Medical College of Georgia, Georgia Regents University, Augusta, GA.
Huijuan Dou
Istvan Czikora
Andras Szabo
Vijay S Patel
Vinayak Kamath
Eric Belin de Chantemele
Attila Feher
Maritza J Romero
Zsolt Bagi
Augusta University · US

Funding

Flow-induced coronary vasospasm in diabetic patientsR01HL104126 · NHLBI · NEW YORK MEDICAL COLLEGE · PI BAGI, ZSOLT · 2010 to 2014
$1.9M
NHLBI NIH HHS R01 HL104126NHLBI NIH HHS R01-HL-104126
6 · The paper itself

Abstract

Peroxynitrite (ONOO(-)) contributes to coronary microvascular dysfunction in diabetes mellitus (DM). We hypothesized that in DM, ONOO(-) interferes with the function of coronary endothelial caveolae, which plays an important role in nitric oxide (NO)-dependent vasomotor regulation. Flow-mediated dilation (FMD) of coronary arterioles was investigated in DM (n = 41) and non-DM (n = 37) patients undergoing heart surgery. NO-mediated coronary FMD was significantly reduced in DM patients, which was restored by ONOO(-) scavenger, iron-(III)-tetrakis(N-methyl-4'pyridyl)porphyrin-pentachloride, or uric acid, whereas exogenous ONOO(-) reduced FMD in non-DM subjects. Immunoelectron microscopy demonstrated an increased 3-nitrotyrosine formation (ONOO(-)-specific protein nitration) in endothelial plasma membrane in DM, which colocalized with caveolin-1 (Cav-1), the key structural protein of caveolae. The membrane-localized Cav-1 was significantly reduced in DM and also in high glucose-exposed coronary endothelial cells. We also found that DM patients exhibited a decreased number of endothelial caveolae, whereas exogenous ONOO(-) reduced caveolae number. Correspondingly, pharmacological (methyl-β-cyclodextrin) or genetic disruption of caveolae (Cav-1 knockout mice) abolished coronary FMD, which was rescued by sepiapterin, the stable precursor of NO synthase (NOS) cofactor, tetrahydrobiopterin. Sepiapterin also restored coronary FMD in DM patients. Thus, we propose that ONOO(-) selectively targets and disrupts endothelial caveolae, which contributes to NOS uncoupling, and, hence, reduced NO-mediated coronary vasodilation in DM patients.

Indexed as

AgedAnimalsArteriolesbeta-CyclodextrinsCaveolaeCaveolin 1Cells, CulturedDiabetes MellitusEndothelial CellsEndothelium, VascularFemaleHumansMaleMiceMice, KnockoutMiddle Aged3-nitrotyrosinebeta-CyclodextrinsCaveolin 1methyl-beta-cyclodextrinNitric OxideNitric Oxide Synthase Type IIINOS3 protein, humanPeroxynitrous AcidPterinssepiapterinTyrosine

Identifiers

PMID24353182
PMCPMC3964507
OpenAlexW2157824615

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.